Global Alvimopan Market Growth 2025-2031

Publication ID:

LPI01252722

Publication Date:

January 28, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Alvimopan market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting 渭-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.
Alvimopan (CAS 156053-89-3) is widely used in Pharmaceutical and Other field. The most proportion of Alvimopan (CAS 156053-89-3) is used in Pharmaceutical, and the proportion in 2019 is 88.64%. Market competition is intense. Merck is the leaders of the industry, and they hold key technologies and patents, with high-end customers.
The 鈥淎lvimopan Industry Forecast鈥� looks at past sales and reviews total world Alvimopan sales in 2024, providing a comprehensive analysis by region and market sector of projected Alvimopan sales for 2025 through 2031. With Alvimopan sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alvimopan industry.
This Insight Report provides a comprehensive analysis of the global Alvimopan landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alvimopan portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Alvimopan market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alvimopan and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alvimopan.
This report presents a comprehensive overview, market shares, and growth opportunities of Alvimopan market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Pharmaceutical Grade
Others
Segmentation by Application:
Pharmaceutical
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
Teva Pharmaceutical Industries Ltd
MSN Life Sciences Private Ltd
Key Questions Addressed in this Report
What is the 10-year outlook for the global Alvimopan market?
What factors are driving Alvimopan market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Alvimopan market opportunities vary by end market size?
How does Alvimopan break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Alvimopan Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Alvimopan by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Alvimopan by Country/Region, 2020, 2024 & 2031
2.2 Alvimopan Segment by Type
2.2.1 Pharmaceutical Grade
2.2.2 Others
2.3 Alvimopan Sales by Type
2.3.1 Global Alvimopan Sales Market Share by Type (2020-2025)
2.3.2 Global Alvimopan Revenue and Market Share by Type (2020-2025)
2.3.3 Global Alvimopan Sale Price by Type (2020-2025)
2.4 Alvimopan Segment by Application
2.4.1 Pharmaceutical
2.4.2 Other
2.5 Alvimopan Sales by Application
2.5.1 Global Alvimopan Sale Market Share by Application (2020-2025)
2.5.2 Global Alvimopan Revenue and Market Share by Application (2020-2025)
2.5.3 Global Alvimopan Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Alvimopan Breakdown Data by Company
3.1.1 Global Alvimopan Annual Sales by Company (2020-2025)
3.1.2 Global Alvimopan Sales Market Share by Company (2020-2025)
3.2 Global Alvimopan Annual Revenue by Company (2020-2025)
3.2.1 Global Alvimopan Revenue by Company (2020-2025)
3.2.2 Global Alvimopan Revenue Market Share by Company (2020-2025)
3.3 Global Alvimopan Sale Price by Company
3.4 Key Manufacturers Alvimopan Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Alvimopan Product Location Distribution
3.4.2 Players Alvimopan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Alvimopan by Geographic Region
4.1 World Historic Alvimopan Market Size by Geographic Region (2020-2025)
4.1.1 Global Alvimopan Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Alvimopan Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Alvimopan Market Size by Country/Region (2020-2025)
4.2.1 Global Alvimopan Annual Sales by Country/Region (2020-2025)
4.2.2 Global Alvimopan Annual Revenue by Country/Region (2020-2025)
4.3 Americas Alvimopan Sales Growth
4.4 APAC Alvimopan Sales Growth
4.5 Europe Alvimopan Sales Growth
4.6 Middle East & Africa Alvimopan Sales Growth
5 Americas
5.1 Americas Alvimopan Sales by Country
5.1.1 Americas Alvimopan Sales by Country (2020-2025)
5.1.2 Americas Alvimopan Revenue by Country (2020-2025)
5.2 Americas Alvimopan Sales by Type (2020-2025)
5.3 Americas Alvimopan Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alvimopan Sales by Region
6.1.1 APAC Alvimopan Sales by Region (2020-2025)
6.1.2 APAC Alvimopan Revenue by Region (2020-2025)
6.2 APAC Alvimopan Sales by Type (2020-2025)
6.3 APAC Alvimopan Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Alvimopan by Country
7.1.1 Europe Alvimopan Sales by Country (2020-2025)
7.1.2 Europe Alvimopan Revenue by Country (2020-2025)
7.2 Europe Alvimopan Sales by Type (2020-2025)
7.3 Europe Alvimopan Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Alvimopan by Country
8.1.1 Middle East & Africa Alvimopan Sales by Country (2020-2025)
8.1.2 Middle East & Africa Alvimopan Revenue by Country (2020-2025)
8.2 Middle East & Africa Alvimopan Sales by Type (2020-2025)
8.3 Middle East & Africa Alvimopan Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Alvimopan
10.3 Manufacturing Process Analysis of Alvimopan
10.4 Industry Chain Structure of Alvimopan
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Alvimopan Distributors
11.3 Alvimopan Customer
12 World Forecast Review for Alvimopan by Geographic Region
12.1 Global Alvimopan Market Size Forecast by Region
12.1.1 Global Alvimopan Forecast by Region (2026-2031)
12.1.2 Global Alvimopan Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Alvimopan Forecast by Type (2026-2031)
12.7 Global Alvimopan Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Alvimopan Product Portfolios and Specifications
13.1.3 Merck Alvimopan Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Teva Pharmaceutical Industries Ltd
13.2.1 Teva Pharmaceutical Industries Ltd Company Information
13.2.2 Teva Pharmaceutical Industries Ltd Alvimopan Product Portfolios and Specifications
13.2.3 Teva Pharmaceutical Industries Ltd Alvimopan Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.2.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.3 MSN Life Sciences Private Ltd
13.3.1 MSN Life Sciences Private Ltd Company Information
13.3.2 MSN Life Sciences Private Ltd Alvimopan Product Portfolios and Specifications
13.3.3 MSN Life Sciences Private Ltd Alvimopan Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 MSN Life Sciences Private Ltd Main Business Overview
13.3.5 MSN Life Sciences Private Ltd Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂